A Safety and Tolerability Study of FCN-207 in Healthy Volunteers
NCT04622124 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2024-08-05
Summary
This research study is studying an investigational drug called FCN-207 in healthy adult males or females.
Conditions
- Hyperuricemia
Interventions
Sponsors & Collaborators
-
Fochon Pharmaceuticals, Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-11
- Primary Completion
- 2021-12-21
- Completion
- 2022-06-07
Countries
- China
Study Locations
More Related Trials
-
Effect of Hyperuricaemia on Chronic Renal Disease
NCT03425708 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose Study of SHR4640 in Healthy Subjects
NCT02815839 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
NCT02287818 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia
NCT04180982 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
NCT00985127 ·Status: COMPLETED ·Phase: PHASE2
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers
NCT03291782 ·Status: COMPLETED ·Phase: PHASE1
-
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
NCT03372200 ·Status: COMPLETED ·Phase: PHASE3
-
The Intervention of Multi-vitamin With Minerals to Hyperuricemia
NCT03218709 ·Status: UNKNOWN ·Phase: PHASE4
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients
NCT03200210 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT03006445 ·Status: COMPLETED ·Phase: PHASE3
-
D-0120 Safety and PK/PD Study in China
NCT03923868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single and Multiple Dose Study in Japanese Subjects
NCT01872832 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia
NCT03185793 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy
NCT04069325 ·Status: UNKNOWN ·Phase: NA
-
the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
NCT02279342 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
NCT04060173 ·Status: COMPLETED ·Phase: PHASE1
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)
NCT03375632 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperuricemia and Diabetic Nephropathy
NCT04799925 ·Status: UNKNOWN
-
SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects
NCT06678581 ·Status: COMPLETED ·Phase: PHASE1